LD
AMGN icon

Lipe & Dalton’s Amgen AMGN Stock Holding History

Lipe & Dalton’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Sell
7,427
-165
-2% -$56.5K 1.25% 27
2026
Q1 		$2.67M Sell
7,592
-794
-9% -$283K 1.4% 27
2025
Q4 		$2.75M Sell
8,386
-210
-2% -$66.6K 1.36% 26
2025
Q3 		$2.43M Sell
8,596
-50
-0.6% -$14.5K 1.2% 31
2025
Q2 		$2.41M Sell
8,646
-225
-3% -$63.7K 1.3% 29
2025
Q1 		$2.76M Buy
8,871
+70
+0.8% +$20.7K 1.55% 22
2024
Q4 		$2.29M Sell
8,801
-115
-1% -$34.1K 1.22% 29
2024
Q3 		$2.87M Sell
8,916
-100
-1% -$32.7K 1.45% 26
2024
Q2 		$2.82M Sell
9,016
-340
-4% -$99.9K 1.52% 24
2024
Q1 		$2.66M Sell
9,356
-70
-0.7% -$20.5K 1.37% 26
2023
Q4 		$2.71M Hold
9,426
– – 1.47% 23
2023
Q3 		$2.53M Hold
9,426
– – 1.52% 22
2023
Q2 		$2.09M Sell
9,426
-205
-2% -$47.6K 1.19% 30
2023
Q1 		$2.33M Sell
9,631
-90
-0.9% -$22.1K 1.33% 27
2022
Q4 		$2.55M Buy
9,721
+40
+0.4% +$10.7K 1.47% 24
2022
Q3 		$2.18M Sell
9,681
-45
-0.5% -$10.9K 1.37% 24
2022
Q2 		$2.37M Sell
9,726
-5,610
-37% -$1.37M 1.38% 25
2022
Q1 		$3.71M Buy
15,336
+10,482
+216% +$2.41M 1.81% 22
2021
Q4 		$1.09M Sell
4,854
-125
-3% -$26.4K 0.52% 50
2021
Q3 		$1.06M Buy
4,979
+755
+18% +$174K 0.54% 48
2021
Q2 		$1.03M Buy
4,224
+3,864
+1,073% +$951K 0.54% 49
2021
Q1 		$90K Hold
360
– – 0.05% 87
2020
Q4 		$83K Hold
360
– – 0.05% 82
2020
Q3 		$91K Hold
360
– – 0.06% 81
2020
Q2 		$85K Hold
360
– – 0.06% 84
2020
Q1 		$73K Hold
360
– – 0.06% 81
2019
Q4 		$87K Sell
360
-6
-2% -$1.32K 0.06% 86
2019
Q3 		$71K Hold
366
– – 0.05% 87
2019
Q2 		$67K Hold
366
– – 0.05% 83
2019
Q1 		$70K Buy
+366
New +$69.9K 0.05% 76

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Lipe & Dalton's AMGN Position: Q2 2026 in Review

Lipe & Dalton reduced its Amgen (AMGN) stake by 2.2% in Q2 2026, selling an estimated $56.5K and leaving 7,427 shares worth $2.69M. The position accounts for 1.25% of the portfolio, ranked #27.

Lipe & Dalton first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.71M in Q1 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lipe & Dalton held 7,427 shares of Amgen worth $2.69M as of Q2 2026.
  • Lipe & Dalton sold 165 Amgen shares in Q2 2026, an estimated $56.5K.
  • Amgen made up 1.25% of Lipe & Dalton's portfolio in Q2 2026, its #27 holding.
  • Lipe & Dalton first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
  • Lipe & Dalton's Amgen position peaked at $3.71M in Q1 2022.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.